bokomslag Second Generation Cell and Gene-Based Therapies
Kropp & själ

Second Generation Cell and Gene-Based Therapies

Alain Vertes Nathan J Dowden Devyn Smith Nasib Qureshi Nathan J Dowden

Inbunden

2179:-

Funktionen begränsas av dina webbläsarinställningar (t.ex. privat läge).

Uppskattad leveranstid 10-16 arbetsdagar

Fri frakt för medlemmar vid köp för minst 249:-

  • 2020
Second Generation Cell and Gene-Based Therapies: Biological Advances, Clinical Outcomes, and Strategies for Capitalisation serves as the only volume to the market to bridge basic science, clinical therapy, technology development, and business in the field of cellular therapy/cytotherapy. After more than two decades of painstaking fundamental research, the concept of therapeutic cells (stem cells, genes, etc.), beyond the concept of vaccines, is reaching clinical trial, with mounting confidence in the safety and efficacy of these products. Nonetheless, numerous incremental technical advances remain to be achieved. Thus, this volume highlights the possible R&D paths, which will ultimately facilitate clinical delivery of cutting edge curative products.The next waves of innovation are reviewed in depth for hematopoietic stem cells, mesenchymal stem cells, tissue engineering, CAR-T cells, and cells of the immune system, as well as for enabling technologies such as gene and genome editing. Additionally, deep dives in product fundamentals, history of science, pathobiology of diseases, scientific and technological bases, and financing and technology adoption constraints are taken to unravel what will shape the cytotherapy industry to the horizon 2025 and beyond. The outcome is not simply a scientific book, but a global perspective on the nascent field combining science, business, and strategic fundamentals.
  • Författare: Alain Vertes, Nathan J Dowden, Devyn Smith, Nasib Qureshi, Nathan J Dowden
  • Format: Inbunden
  • ISBN: 9780128120347
  • Språk: Engelska
  • Utgivningsdatum: 2020-02-10
  • Förlag: Elsevier Science Publishing Co Inc